Global Information
회사소개 | 문의 | 비교리스트

세계의 원내감염 제어 시장

Hospital Acquired Infection Control

리서치사 Global Industry Analysts, Inc.
발행일 2020년 07월 상품 코드 947387
페이지 정보 영문 289 Pages
가격
US $ 5,450 ₩ 6,530,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,350 ₩ 19,590,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 원내감염 제어 시장 Hospital Acquired Infection Control
발행일 : 2020년 07월 페이지 정보 : 영문 289 Pages

COVID-19 위기에서 2020년에 55억 달러로 추정되는 세계의 원내감염 제어 시장은 2027년까지 69억 달러에 달하며, 2020-2027년의 분석 기간 중 3.3%의 CAGR로 성장할 것으로 예측되고 있습니다. 이 조사에서 분석된 부문의 하나인 열멸균기는 분석 기간말까지 3.1%의 CAGR로 성장하며, 15억 달러에 달할 것으로 예측되고 있습니다.

원내감염 제어 시장을 조사했으며, 시장의 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이와 예측, 각종 부문·지역·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등을 정리하여 전해드립니다.

조사 대상 기업의 예

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB(Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

목차

I. 서론, 조사 방법 , 조사 범위

II. 개요

제1장 시장 개요

  • 세계 경쟁사의 시장 점유율
  • 세계의 원내감염 제어 경쟁 시장 점유율 시나리오(%) : 2019년 및 2025년
  • Covid-19의 영향과 다가오는 세계의 경기후퇴

제2장 주요 기업

제3장 시장 동향과 촉진요인

제4장 세계 시장의 전망

III. 시장 분석

  • 지역별 시장 분석
  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

IV. 경쟁

  • 기업 개요 : 46
KSA 20.07.28

Global Hospital Acquired Infection Control Market to Reach $6.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Hospital Acquired Infection Control estimated at US$5.5 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 3.3% over the analysis period 2020-2027. Heat Sterilization Equipment, one of the segments analyzed in the report, is projected to record a 3.1% CAGR and reach US$1.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Low Temperature Sterilization Equipment segment is readjusted to a revised 3.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 6% CAGR

The Hospital Acquired Infection Control market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 5.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 2.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Radiation Sterilization Equipment Segment to Record 2.9% CAGR

In the global Radiation Sterilization Equipment segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$822.3 Million in the year 2020 will reach a projected size of US$975.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$962.2 Million by the year 2027, while Latin America will expand at a 3.7% CAGR through the analysis period. We bring years of research experience to this 5th edition of our report. The 289-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Hospital Acquired Infection Control Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Hospital Acquired Infection Control Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Hospital Acquired Infection Control Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Hospital Acquired Infection Control Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Heat Sterilization Equipment (Product) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Heat Sterilization Equipment (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Heat Sterilization Equipment (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Low Temperature Sterilization Equipment (Product) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Low Temperature Sterilization Equipment (Product) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Low Temperature Sterilization Equipment (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Radiation Sterilization Equipment (Product) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Radiation Sterilization Equipment (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Radiation Sterilization Equipment (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Disinfection Equipment (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Disinfection Equipment (Product) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Disinfection Equipment (Product) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Hospitals (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 17: Hospitals (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 18: Hospitals (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Ambulatory Surgical Centers (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Ambulatory Surgical Centers (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Ambulatory Surgical Centers (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Diagnostic Laboratories (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Diagnostic Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Diagnostic Laboratories (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Other End-Uses (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Hospital Acquired Infection Control Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 28: United States Hospital Acquired Infection Control Market Estimates and Projections in US$ Million by Product: 2020 to 2027
    • TABLE 29: Hospital Acquired Infection Control Market in the United States by Product:
    • A Historic Review in US$ Million for 2012-2019
    • TABLE 30: United States Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 31: United States Hospital Acquired Infection Control Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 32: Hospital Acquired Infection Control Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
    • TABLE 33: Hospital Acquired Infection Control Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 34: Canadian Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020 to 2027
    • TABLE 35: Canadian Hospital Acquired Infection Control Historic Market Review by Product in US$ Million: 2012-2019
    • TABLE 36: Hospital Acquired Infection Control Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
    • TABLE 37: Canadian Hospital Acquired Infection Control Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 38: Hospital Acquired Infection Control Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 39: Canadian Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 40: Japanese Market for Hospital Acquired Infection Control: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
    • TABLE 41: Hospital Acquired Infection Control Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2012-2019
    • TABLE 42: Japanese Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 43: Japanese Demand Estimates and Forecasts for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 44: Japanese Hospital Acquired Infection Control Market in US$ Million by End-Use: 2012-2019
    • TABLE 45: Hospital Acquired Infection Control Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 46: Chinese Hospital Acquired Infection Control Market Growth Prospects in US$ Million by Product for the Period 2020-2027
    • TABLE 47: Hospital Acquired Infection Control Historic Market Analysis in China in US$ Million by Product: 2012-2019
    • TABLE 48: Chinese Hospital Acquired Infection Control Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 49: Chinese Demand for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 50: Hospital Acquired Infection Control Market Review in China in US$ Million by End-Use: 2012-2019
    • TABLE 51: Chinese Hospital Acquired Infection Control Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Hospital Acquired Infection Control Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 52: European Hospital Acquired Infection Control Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 53: Hospital Acquired Infection Control Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 54: European Hospital Acquired Infection Control Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 55: European Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020-2027
    • TABLE 56: Hospital Acquired Infection Control Market in Europe in US$ Million by Product: A Historic Review for the Period 2012-2019
    • TABLE 57: European Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 58: European Hospital Acquired Infection Control Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 59: Hospital Acquired Infection Control Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 60: European Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 61: Hospital Acquired Infection Control Market in France by Product: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 62: French Hospital Acquired Infection Control Historic Market Scenario in US$ Million by Product: 2012-2019
    • TABLE 63: French Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 64: Hospital Acquired Infection Control Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
    • TABLE 65: French Hospital Acquired Infection Control Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 66: French Hospital Acquired Infection Control Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 67: Hospital Acquired Infection Control Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
    • TABLE 68: German Hospital Acquired Infection Control Historic Market Analysis in US$ Million by Product: 2012-2019
    • TABLE 69: German Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 70: Hospital Acquired Infection Control Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 71: German Hospital Acquired Infection Control Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 72: Hospital Acquired Infection Control Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 73: Italian Hospital Acquired Infection Control Market Growth Prospects in US$ Million by Product for the Period 2020-2027
    • TABLE 74: Hospital Acquired Infection Control Historic Market Analysis in Italy in US$ Million by Product: 2012-2019
    • TABLE 75: Italian Hospital Acquired Infection Control Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 76: Italian Demand for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 77: Hospital Acquired Infection Control Market Review in Italy in US$ Million by End-Use: 2012-2019
    • TABLE 78: Italian Hospital Acquired Infection Control Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 79: United Kingdom Market for Hospital Acquired Infection Control: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
    • TABLE 80: Hospital Acquired Infection Control Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2012-2019
    • TABLE 81: United Kingdom Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 82: United Kingdom Demand Estimates and Forecasts for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 83: United Kingdom Hospital Acquired Infection Control Market in US$ Million by End-Use: 2012-2019
    • TABLE 84: Hospital Acquired Infection Control Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 85: Spanish Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020 to 2027
    • TABLE 86: Spanish Hospital Acquired Infection Control Historic Market Review by Product in US$ Million: 2012-2019
    • TABLE 87: Hospital Acquired Infection Control Market in Spain: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
    • TABLE 88: Spanish Hospital Acquired Infection Control Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 89: Hospital Acquired Infection Control Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 90: Spanish Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • RUSSIA
    • TABLE 91: Russian Hospital Acquired Infection Control Market Estimates and Projections in US$ Million by Product: 2020 to 2027
    • TABLE 92: Hospital Acquired Infection Control Market in Russia by Product: A Historic Review in US$ Million for 2012-2019
    • TABLE 93: Russian Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 94: Russian Hospital Acquired Infection Control Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 95: Hospital Acquired Infection Control Historic Demand Patterns in Russia by End-Use in US$ Million for 2012-2019
    • TABLE 96: Hospital Acquired Infection Control Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 97: Rest of Europe Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020-2027
    • TABLE 98: Hospital Acquired Infection Control Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2012-2019
    • TABLE 99: Rest of Europe Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 100: Rest of Europe Hospital Acquired Infection Control Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 101: Hospital Acquired Infection Control Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 102: Rest of Europe Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 103: Asia-Pacific Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 104: Hospital Acquired Infection Control Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 105: Asia-Pacific Hospital Acquired Infection Control Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 106: Hospital Acquired Infection Control Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 107: Asia-Pacific Hospital Acquired Infection Control Historic Market Scenario in US$ Million by Product: 2012-2019
    • TABLE 108: Asia-Pacific Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 109: Hospital Acquired Infection Control Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
    • TABLE 110: Asia-Pacific Hospital Acquired Infection Control Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 111: Asia-Pacific Hospital Acquired Infection Control Market Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and 2027
  • AUSTRALIA
    • TABLE 112: Hospital Acquired Infection Control Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
    • TABLE 113: Australian Hospital Acquired Infection Control Historic Market Analysis in US$ Million by Product: 2012-2019
    • TABLE 114: Australian Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 115: Hospital Acquired Infection Control Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 116: Australian Hospital Acquired Infection Control Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 117: Hospital Acquired Infection Control Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 118: Indian Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020 to 2027
    • TABLE 119: Indian Hospital Acquired Infection Control Historic Market Review by Product in US$ Million: 2012-2019
    • TABLE 120: Hospital Acquired Infection Control Market in India: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
    • TABLE 121: Indian Hospital Acquired Infection Control Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 122: Hospital Acquired Infection Control Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 123: Indian Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • SOUTH KOREA
    • TABLE 124: Hospital Acquired Infection Control Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
    • TABLE 125: South Korean Hospital Acquired Infection Control Historic Market Analysis in US$ Million by Product: 2012-2019
    • TABLE 126: Hospital Acquired Infection Control Market Share Distribution in South Korea by Product: 2012 VS 2020 VS 2027
    • TABLE 127: Hospital Acquired Infection Control Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
    • TABLE 128: South Korean Hospital Acquired Infection Control Historic Market Analysis in US$ Million by End-Use: 2012-2019
    • TABLE 129: Hospital Acquired Infection Control Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 130: Rest of Asia-Pacific Market for Hospital Acquired Infection Control: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
    • TABLE 131: Hospital Acquired Infection Control Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2012-2019
    • TABLE 132: Rest of Asia-Pacific Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 133: Rest of Asia-Pacific Demand Estimates and Forecasts for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 134: Rest of Asia-Pacific Hospital Acquired Infection Control Market in US$ Million by End-Use: 2012-2019
    • TABLE 135: Hospital Acquired Infection Control Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 136: Latin American Hospital Acquired Infection Control Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 137: Hospital Acquired Infection Control Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 138: Latin American Hospital Acquired Infection Control Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 139: Latin American Hospital Acquired Infection Control Market Growth Prospects in US$ Million by Product for the Period 2020-2027
    • TABLE 140: Hospital Acquired Infection Control Historic Market Analysis in Latin America in US$ Million by Product: 2012-2019
    • TABLE 141: Latin American Hospital Acquired Infection Control Marketby Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 142: Latin American Demand for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 143: Hospital Acquired Infection Control Market Review in Latin America in US$ Million by End-Use: 2012-2019
    • TABLE 144: Latin American Hospital Acquired Infection Control Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • ARGENTINA
    • TABLE 145: Argentinean Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020-2027
    • TABLE 146: Hospital Acquired Infection Control Market in Argentina in US$ Million by Product: A Historic Review for the Period 2012-2019
    • TABLE 147: Argentinean Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 148: Argentinean Hospital Acquired Infection Control Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 149: Hospital Acquired Infection Control Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 150: Argentinean Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 151: Hospital Acquired Infection Control Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 152: Brazilian Hospital Acquired Infection Control Historic Market Scenario in US$ Million by Product: 2012-2019
    • TABLE 153: Brazilian Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 154: Hospital Acquired Infection Control Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020-2027
    • TABLE 155: Brazilian Hospital Acquired Infection Control Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 156: Brazilian Hospital Acquired Infection Control Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • MEXICO
    • TABLE 157: Hospital Acquired Infection Control Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
    • TABLE 158: Mexican Hospital Acquired Infection Control Historic Market Analysis in US$ Million by Product: 2012-2019
    • TABLE 159: Mexican Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 160: Hospital Acquired Infection Control Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 161: Mexican Hospital Acquired Infection Control Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 162: Hospital Acquired Infection Control Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 163: Rest of Latin America Hospital Acquired Infection Control Market Estimates and Projections in US$ Million by Product: 2020 to 2027
    • TABLE 164: Hospital Acquired Infection Control Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2012-2019
    • TABLE 165: Rest of Latin America Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 166: Rest of Latin America Hospital Acquired Infection Control Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 167: Hospital Acquired Infection Control Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012-2019
    • TABLE 168: Hospital Acquired Infection Control Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 169: The Middle East Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 170: Hospital Acquired Infection Control Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 171: The Middle East Hospital Acquired Infection Control Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 172: The Middle East Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020 to 2027
    • TABLE 173: The Middle East Hospital Acquired Infection Control Historic Marketby Product in US$ Million: 2012-2019
    • TABLE 174: Hospital Acquired Infection Control Market in the Middle East: Percentage Share Breakdown of Salesby Product for 2012,2020, and 2027
    • TABLE 175: The Middle East Hospital Acquired Infection Control Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 176: Hospital Acquired Infection Control Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 177: The Middle East Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • IRAN
    • TABLE 178: Iranian Market for Hospital Acquired Infection Control: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
    • TABLE 179: Hospital Acquired Infection Control Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2012-2019
    • TABLE 180: Iranian Hospital Acquired Infection Control Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 181: Iranian Demand Estimates and Forecasts for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 182: Iranian Hospital Acquired Infection Control Market in US$ Million by End-Use: 2012-2019
    • TABLE 183: Hospital Acquired Infection Control Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 184: Israeli Hospital Acquired Infection Control Market Estimates and Forecasts in US$ Million by Product: 2020-2027
    • TABLE 185: Hospital Acquired Infection Control Market in Israel in US$ Million by Product: A Historic Review for the Period 2012-2019
    • TABLE 186: Israeli Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 187: Israeli Hospital Acquired Infection Control Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 188: Hospital Acquired Infection Control Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 189: Israeli Hospital Acquired Infection Control Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 190: Saudi Arabian Hospital Acquired Infection Control Market Growth Prospects in US$ Million by Product for the Period 2020-2027
    • TABLE 191: Hospital Acquired Infection Control Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2012-2019
    • TABLE 192: Saudi Arabian Hospital Acquired Infection Control Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 193: Saudi Arabian Demand for Hospital Acquired Infection Control in US$ Million by End-Use: 2020 to 2027
    • TABLE 194: Hospital Acquired Infection Control Market Review in Saudi Arabia in US$ Million by End-Use: 2012-2019
    • TABLE 195: Saudi Arabian Hospital Acquired Infection Control Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED ARAB EMIRATES
    • TABLE 196: Hospital Acquired Infection Control Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
    • TABLE 197: United Arab Emirates Hospital Acquired Infection Control Historic Market Analysis in US$ Million by Product: 2012-2019
    • TABLE 198: Hospital Acquired Infection Control Market Share Distribution in United Arab Emirates by Product: 2012 VS 2020 VS 2027
    • TABLE 199: Hospital Acquired Infection Control Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
    • TABLE 200: United Arab Emirates Hospital Acquired Infection Control Historic Market Analysis in US$ Million by End-Use: 2012-2019
    • TABLE 201: Hospital Acquired Infection Control Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 202: Hospital Acquired Infection Control Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
    • TABLE 203: Rest of Middle East Hospital Acquired Infection Control Historic Market Analysis in US$ Million by Product: 2012-2019
    • TABLE 204: Rest of Middle East Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 205: Hospital Acquired Infection Control Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 206: Rest of Middle East Hospital Acquired Infection Control Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 207: Hospital Acquired Infection Control Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 208: African Hospital Acquired Infection Control Market Estimates and Projections in US$ Million by Product: 2020 to 2027
    • TABLE 209: Hospital Acquired Infection Control Market in Africa by Product: A Historic Review in US$ Million for 2012-2019
    • TABLE 210: African Hospital Acquired Infection Control Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 211: African Hospital Acquired Infection Control Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 212: Hospital Acquired Infection Control Historic Demand Patterns in Africa by End-Use in US$ Million for 2012-2019
    • TABLE 213: Hospital Acquired Infection Control Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 46
Back to Top
전화 문의
F A Q